Center-Authored Papers

Filters: Author is Montgomery, Robert Bruce  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
Xenograft Model Antitumor Assays
Koreckij TD, Trauger RJ, Montgomery RB, Pitts TEM, Coleman I, Nguyen H, Reading CL, Nelson PS, Vessella RL, Corey E.  2009.  HE3235 inhibits growth of castration-resistant prostate cancer.. Neoplasia (New York, N.Y.). 11(11):1216-25. Abstract
Treatment Outcome
Yu EY, Muzi M, Hackenbracht JA, Rezvani BB, Link JM, Montgomery RB, Higano CS, Eary JF, Mankoff DA.  2011.  C11-acetate and F-18 FDG PET for men with prostate cancer bone metastases: relative findings and response to therapy.. Clinical nuclear medicine. 36(3):192-8. Abstract
TESTOSTERONE
Koreckij TD, Trauger RJ, Montgomery RB, Pitts TEM, Coleman I, Nguyen H, Reading CL, Nelson PS, Vessella RL, Corey E.  2009.  HE3235 inhibits growth of castration-resistant prostate cancer.. Neoplasia (New York, N.Y.). 11(11):1216-25. Abstract
Taxoids
Yu EY, Muzi M, Hackenbracht JA, Rezvani BB, Link JM, Montgomery RB, Higano CS, Eary JF, Mankoff DA.  2011.  C11-acetate and F-18 FDG PET for men with prostate cancer bone metastases: relative findings and response to therapy.. Clinical nuclear medicine. 36(3):192-8. Abstract
Shared Resources
Koreckij TD, Trauger RJ, Montgomery RB, Pitts TEM, Coleman I, Nguyen H, Reading CL, Nelson PS, Vessella RL, Corey E.  2009.  HE3235 inhibits growth of castration-resistant prostate cancer.. Neoplasia (New York, N.Y.). 11(11):1216-25. Abstract
Reverse Transcriptase Polymerase Chain Reaction
Koreckij TD, Trauger RJ, Montgomery RB, Pitts TEM, Coleman I, Nguyen H, Reading CL, Nelson PS, Vessella RL, Corey E.  2009.  HE3235 inhibits growth of castration-resistant prostate cancer.. Neoplasia (New York, N.Y.). 11(11):1216-25. Abstract
Receptors, Androgen
Koreckij TD, Trauger RJ, Montgomery RB, Pitts TEM, Coleman I, Nguyen H, Reading CL, Nelson PS, Vessella RL, Corey E.  2009.  HE3235 inhibits growth of castration-resistant prostate cancer.. Neoplasia (New York, N.Y.). 11(11):1216-25. Abstract
Prostatic Neoplasms
Yu EY, Muzi M, Hackenbracht JA, Rezvani BB, Link JM, Montgomery RB, Higano CS, Eary JF, Mankoff DA.  2011.  C11-acetate and F-18 FDG PET for men with prostate cancer bone metastases: relative findings and response to therapy.. Clinical nuclear medicine. 36(3):192-8. Abstract
Koreckij TD, Trauger RJ, Montgomery RB, Pitts TEM, Coleman I, Nguyen H, Reading CL, Nelson PS, Vessella RL, Corey E.  2009.  HE3235 inhibits growth of castration-resistant prostate cancer.. Neoplasia (New York, N.Y.). 11(11):1216-25. Abstract
Positron-Emission Tomography
Yu EY, Muzi M, Hackenbracht JA, Rezvani BB, Link JM, Montgomery RB, Higano CS, Eary JF, Mankoff DA.  2011.  C11-acetate and F-18 FDG PET for men with prostate cancer bone metastases: relative findings and response to therapy.. Clinical nuclear medicine. 36(3):192-8. Abstract
Neoplasm Metastasis
Koreckij TD, Trauger RJ, Montgomery RB, Pitts TEM, Coleman I, Nguyen H, Reading CL, Nelson PS, Vessella RL, Corey E.  2009.  HE3235 inhibits growth of castration-resistant prostate cancer.. Neoplasia (New York, N.Y.). 11(11):1216-25. Abstract
Mice, Nude
Koreckij TD, Trauger RJ, Montgomery RB, Pitts TEM, Coleman I, Nguyen H, Reading CL, Nelson PS, Vessella RL, Corey E.  2009.  HE3235 inhibits growth of castration-resistant prostate cancer.. Neoplasia (New York, N.Y.). 11(11):1216-25. Abstract
MICE
Koreckij TD, Trauger RJ, Montgomery RB, Pitts TEM, Coleman I, Nguyen H, Reading CL, Nelson PS, Vessella RL, Corey E.  2009.  HE3235 inhibits growth of castration-resistant prostate cancer.. Neoplasia (New York, N.Y.). 11(11):1216-25. Abstract
Male
Koreckij TD, Trauger RJ, Montgomery RB, Pitts TEM, Coleman I, Nguyen H, Reading CL, Nelson PS, Vessella RL, Corey E.  2009.  HE3235 inhibits growth of castration-resistant prostate cancer.. Neoplasia (New York, N.Y.). 11(11):1216-25. Abstract
Yu EY, Muzi M, Hackenbracht JA, Rezvani BB, Link JM, Montgomery RB, Higano CS, Eary JF, Mankoff DA.  2011.  C11-acetate and F-18 FDG PET for men with prostate cancer bone metastases: relative findings and response to therapy.. Clinical nuclear medicine. 36(3):192-8. Abstract
Immunohistochemistry
Koreckij TD, Trauger RJ, Montgomery RB, Pitts TEM, Coleman I, Nguyen H, Reading CL, Nelson PS, Vessella RL, Corey E.  2009.  HE3235 inhibits growth of castration-resistant prostate cancer.. Neoplasia (New York, N.Y.). 11(11):1216-25. Abstract
Humans
Koreckij TD, Trauger RJ, Montgomery RB, Pitts TEM, Coleman I, Nguyen H, Reading CL, Nelson PS, Vessella RL, Corey E.  2009.  HE3235 inhibits growth of castration-resistant prostate cancer.. Neoplasia (New York, N.Y.). 11(11):1216-25. Abstract
Yu EY, Muzi M, Hackenbracht JA, Rezvani BB, Link JM, Montgomery RB, Higano CS, Eary JF, Mankoff DA.  2011.  C11-acetate and F-18 FDG PET for men with prostate cancer bone metastases: relative findings and response to therapy.. Clinical nuclear medicine. 36(3):192-8. Abstract
Human Biology Division
Koreckij TD, Trauger RJ, Montgomery RB, Pitts TEM, Coleman I, Nguyen H, Reading CL, Nelson PS, Vessella RL, Corey E.  2009.  HE3235 inhibits growth of castration-resistant prostate cancer.. Neoplasia (New York, N.Y.). 11(11):1216-25. Abstract
Genomics Core Facility
Koreckij TD, Trauger RJ, Montgomery RB, Pitts TEM, Coleman I, Nguyen H, Reading CL, Nelson PS, Vessella RL, Corey E.  2009.  HE3235 inhibits growth of castration-resistant prostate cancer.. Neoplasia (New York, N.Y.). 11(11):1216-25. Abstract
gene expression
Koreckij TD, Trauger RJ, Montgomery RB, Pitts TEM, Coleman I, Nguyen H, Reading CL, Nelson PS, Vessella RL, Corey E.  2009.  HE3235 inhibits growth of castration-resistant prostate cancer.. Neoplasia (New York, N.Y.). 11(11):1216-25. Abstract
Fluorodeoxyglucose F18
Yu EY, Muzi M, Hackenbracht JA, Rezvani BB, Link JM, Montgomery RB, Higano CS, Eary JF, Mankoff DA.  2011.  C11-acetate and F-18 FDG PET for men with prostate cancer bone metastases: relative findings and response to therapy.. Clinical nuclear medicine. 36(3):192-8. Abstract
DIHYDROTESTOSTERONE
Koreckij TD, Trauger RJ, Montgomery RB, Pitts TEM, Coleman I, Nguyen H, Reading CL, Nelson PS, Vessella RL, Corey E.  2009.  HE3235 inhibits growth of castration-resistant prostate cancer.. Neoplasia (New York, N.Y.). 11(11):1216-25. Abstract
Clinical Research Division
Yu EY, Muzi M, Hackenbracht JA, Rezvani BB, Link JM, Montgomery RB, Higano CS, Eary JF, Mankoff DA.  2011.  C11-acetate and F-18 FDG PET for men with prostate cancer bone metastases: relative findings and response to therapy.. Clinical nuclear medicine. 36(3):192-8. Abstract
Center-Authored Paper
Koreckij TD, Trauger RJ, Montgomery RB, Pitts TEM, Coleman I, Nguyen H, Reading CL, Nelson PS, Vessella RL, Corey E.  2009.  HE3235 inhibits growth of castration-resistant prostate cancer.. Neoplasia (New York, N.Y.). 11(11):1216-25. Abstract